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Newcastle disease virus (NDV) is the causative agent of the Newcastle disease (ND) that 
remains as a major threat to the world poultry industry. The virus belongs to the family 
Paramyxoviridae and genus Avulavirus, infects more than 236 avian species, and causes 
up to 100% morbidity and mortality in susceptible birds. The viral envelope proteins, 
haemagglutinin-neuraminidase (HN) and fusion (F) proteins have been shown to play 
key roles in triggering the host immune responses. In order to study the immunological 
properties of the recombinant HN and F proteins, the HN and F genes of the Malaysian 
viscerotropic-velogenic NDV strain AF2240 were obtained through reverse 
transcription-polymerase chain reaction (RT-PCR) and cloned into the Pichia pastoris, 
Saccharomyces cerevisiae and Escherichia coli expression vectors. 
 
A number of eight recombinant plasmids were constructed, namely pPICZαA/HN and 
pPICZαA/F (P. pastoris system), pYES2α/HN and pYES2α/F (S. cerevisiae system), 
and pRSETA/HN, pRSETB/F, pET-43.1a/HN and pET-43.1a/F (E. coli system). The 
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recombinant plasmids were used to transform respective host cells, which were then 
induced for the production of the recombinant HN and F proteins. However, there was 
no protein expression observed in the recombinant P. pastoris and S. cerevisiae cells. 
Whereas, the bacterial hosts were found expressing the recombinant HN and F proteins 
(from the pRSETA/HN and pRSETB/F plasmids respectively), and the NusA fusion 
proteins, NusA-HN and NusA-F (from the pET-43.1a/HN and pET-43.1a/F plasmids 
respectively). The recombinant HN and F proteins were produced as insoluble inclusion 
bodies (IB) while the NusA-HN and NusA-F proteins were expressed in soluble form in 
E. coli.  
 
The recombinant proteins were purified and used to immunise specific pathogen-free 
(SPF) chickens. ELISA results revealed that the insoluble and urea-solubilised inclusion 
bodies of the recombinant HN and F proteins, and the soluble NusA-HN and NusA-F 
proteins stimulated the production of antibodies that detect NDV. Among these antigens, 
the urea-solubilised HN IB appeared to induce the highest antibody titers. However, the 
chicken antibodies failed to neutralise the viral activities as shown in the tests such as 
haemagglutination inhibition (HI), neuraminidase inhibition (NI) and haemolysis 
inhibition (HLI). This explains the susceptibility of the immunised flocks to NDV 
infection upon the viral challenge. Despite of the presence of antibodies to NDV, none 
of the immunised chicken was protected against the viral challenge. Immunoblotting 
analysis on the interactions between the antigens and antibodies revealed that the anti-F 
antibodies did not bind to the denatured viral F glycoprotein, neither the anti-NDV 
serum detect the recombinant F protein. However, the anti-HN antibodies showed 
positive signals when used to probe the denatured viral HN glycoprotein, and in return, 
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the anti-NDV serum detected the recombinant HN protein. This finding indicates the 
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Virus penyakit Newcastle (NDV) merupakan agen penyebab bagi penyakit Newcastle 
(ND) yang masih menjadi ancaman utama kepada industri ayam sedunia. Virus ini 
berada dalam famili Paramyxoviridae dan genus Avulavirus. Ia menjangkiti lebih 
daripada 236 spesis burung dan boleh menyebabkan morbiditi dan mortaliti setinggi 
100% dalam burung-burung yang terjangkit. Protein selaput virus, iaitu protein 
hemaglutinin-neuraminidase (HN) and protein pertaupan (F) telah ditunjukkan 
memainkan peranan yang penting dalam merangsangkan tindakbalas keimunan. Untuk 
mengkaji sifat-sifat imunologik protein rekombinan HN dan F, maka gen-gen HN and F 
bagi strain AF2240 NDV Malaysia yang viscerotropik-velogenik diperolehi menerusi 
transkripsi terbalik-tindakbalas rantaian polimerase (RT-PCR) dan seterusnya diklon ke 





Sejumlah lapan plasmid rekombinan telah dibina, iaitu pPICZαA/HN dan pPICZαA/F 
(sistem P. pastoris), pYES2α/HN dan pYES2α/F (sistem S. cerevisiae), serta 
pRSETA/HN, pRSETB/F, pET-43.1a/HN dan pET-43.1a/F (sistem E. coli). Plasmid 
rekombinan ini digunakan untuk mentransfomkan sel perumah masing-masing, yang 
seterusnya diaruh untuk penghasilan protein rekombinan HN dan F. Namun, tiada 
pengekspresan protein diperhatikan dalam sel rekombinan P. pastoris dan S. cerevisiae. 
Manakala perumah bakteria telah didapati bahawa ianya mengekspreskan protein 
rekombinan HN dan F (dari plasmid pRSETA/HN and pRSETB/F masing-masing), serta 
protein yang bergabungan dengan NusA, iaitu NusA-HN dan NusA-F (dari plasmid 
pET-43.1a/HN dan pET-43.1a/F masing-masing). Protein-protein rekombinan HN dan F 
dihasilkan sebagai badan inklusi (IB) yang tak terlarutkan, sementara protein NusA-HN 
dan NusA-F telah diekspreskan dalam bentuk terlarutkan dalam E. coli.  
 
Protein rekombinan ini ditulenkan dan seterusnya digunakan untuk mengimunkan ayam 
bebas patogen spesifik (SPF). Keputusan ELISA menunjukkan bahawa badan inklusi tak 
terlarutkan dan terlarutkan urea bagi protein-protein rekombinan HN dan F, serta protein 
NusA-HN dan NusA-F yang terlarutkan berjaya merangsangkan penghasilan antibodi 
yang mengesan NDV. Antara antigen ini, badan inklusi HN yang dilarutkan dalam urea 
telah mencetuskan titer antibodi yang tertinggi. Walau bagaimanapun, antibodi ayam ini 
gagal menuetralkan aktiviti virus sebagaimana yang ditunjukkan dalam ujian seperti 
perencatan hemaglutinasi (HI), perencatan neuraminidase (NI) dan perencatan hemolisis 
(HLI). Ini menjelaskan keterjangkitan NDV terhadap ayam yang telah diimunkan itu 
setelah dicabar dengan virus tersebut. Walaupun terdapatnya antibodi terhadap NDV, 
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namun tiada ayam yang diimunkan itu terlindung daripada cabaran virus. Analisis 
immunoblot terhadap interaksi di antara antigen dan antibodi menunjukkan bahawa 
antibodi anti-F tidak mengenali glikoprotein F virus yang nyahasli, begitu juga dengan 
serum anti-NDV yang tidak mengesan protein rekombinan F. Namun, antibody anti-HN 
mengikat glikoprotein HN virus yang nyahasli, begitu juga dengan serum anti-NDV 
yang dapat mengesan protein rekombinan HN. Penemuan ini menunjukkan potensi 
kegunaan protein HN yang dihasilkan dalam E. coli ini sebagai antigen dalam 
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